4.6 Article

Severe and recurrent episodes of bronchiolitis obliterans organising pneumonia associated with indolent CD4+CD8+T-cell leukaemia

期刊

EUROPEAN RESPIRATORY JOURNAL
卷 31, 期 6, 页码 1368-1372

出版社

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00061907

关键词

bronchiolitis obliterans and organising pneumonia; CC chemokine receptor 6; CD103; double-positive T-cells; indolent T-prolymphocytic leukaemia; interstitial lung disease

资金

  1. ICREA Funding Source: Custom

向作者/读者索取更多资源

The present study describes an adult male who has had recurrent episodes of pulmonary infiltrates with severe acute respiratory failure over a period of 10 yrs. Clinical and pathological characteristics revealed bronchiolitis obliterans with organising pneumonia (BOOP) that responded dramatically to prednisone. BOOP is characterised by inflammation of the bronchioles and surrounding tissue in the lungs. It can mimic infectious pneumonia but diagnosis is suspected when there is no response to multiple antibiotic treatment, and blood and sputum cultures are negative for microorganisms. A high proportion of double-positive (DP)-T-cells was detected in peripheral blood and in bronchoalveolar lavage, expressing CD4 and CD8a beta heterodimer with memory phenotype. These DP-T-lymphocytes expressed specific homing molecules that could explain their tropism to lung tissue, giving rise to the clinical symptoms. The patient did not present organomegaly, lymphadenopathy, lymphocytosis or other features of malignancy. However, T-cell receptor V beta chain analysis indicated clonal rearrangement, and cytogenetic studies displayed chromosomic alterations that were similar to clonal proliferation observed in ataxia-telangiectasia and T-prolymphocytic leukaemia. The findings suggest a smouldering form of lymphoproliferation, the first sign of which was bronchiolitis obliterans organising pneumonia requiring constant corticoid treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据